Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2026)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$518.97
Total Value
$165.55K
Shares Held After
1,668
% of Holdings
16.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
598
Price
$517.85
Total Value
$309.68K
Shares Held After
1,987
% of Holdings
23.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
872
Price
$517.02
Total Value
$450.84K
Shares Held After
2,585
% of Holdings
25.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
768
Price
$515.99
Total Value
$396.28K
Shares Held After
3,457
% of Holdings
18.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,064
Price
$515.15
Total Value
$548.12K
Shares Held After
4,225
% of Holdings
20.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,042
Price
$514.02
Total Value
$535.61K
Shares Held After
5,289
% of Holdings
16.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,360
Price
$512.83
Total Value
$697.45K
Shares Held After
6,331
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
722
Price
$511.95
Total Value
$369.63K
Shares Held After
7,691
% of Holdings
8.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
311
Price
$511.05
Total Value
$158.94K
Shares Held After
8,413
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
427
Price
$509.66
Total Value
$217.63K
Shares Held After
8,724
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$508.49
Total Value
$162.21K
Shares Held After
9,151
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$507.27
Total Value
$81.16K
Shares Held After
9,470
% of Holdings
1.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
181
Price
$25.91
Total Value
$4.69K
Shares Held After
121,150
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
6,106
Price
$25.16
Total Value
$153.63K
Shares Held After
121,295
% of Holdings
4.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Pinion John Richard — EVP, Chief Quality Operations Officer
Shares
10,029
Price
$22.80
Total Value
$228.66K
Shares Held After
110,026
% of Holdings
8.4%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
5,066
Price
$9.41
Total Value
$47.67K
Shares Held After
56,739
% of Holdings
8.2%
CVRx, Inc. (CVRX)
John Robert Allen — Chief Revenue Officer
Shares
3,964
Price
$7.90
Total Value
$31.33K
Shares Held After
86,036
% of Holdings
4.4%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$2.28
Total Value
$2.28K
Shares Held After
372,702
% of Holdings
0.3%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
627,813
% of Holdings
0.3%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
13,885
Price
$52.29
Total Value
$726.05K
Shares Held After
59,689
% of Holdings
18.9%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
834
Price
$12.36
Total Value
$10.31K
Shares Held After
139,486
% of Holdings
0.6%
iRhythm Holdings, Inc. (IRTC)
Shrishrimal Sumi — EVP, Chief Risk Officer
Shares
978
Price
$128.44
Total Value
$125.62K
Shares Held After
41,870
% of Holdings
2.3%
iRhythm Holdings, Inc. (IRTC)
Shrishrimal Sumi — EVP, Chief Risk Officer
Shares
906
Price
$128.44
Total Value
$116.37K
Shares Held After
42,848
% of Holdings
2.1%
iRhythm Holdings, Inc. (IRTC)
Shrishrimal Sumi — EVP, Chief Risk Officer
Shares
946
Price
$128.44
Total Value
$121.50K
Shares Held After
43,754
% of Holdings
2.1%
Bausch Health Companies Inc. (BHC)
Carson Seana — EVP, General Counsel
Shares
6,856
Price
$5.78
Total Value
$39.63K
Shares Held After
776,076
% of Holdings
0.9%
Beta Bionics, Inc. (BBNX)
Russell Steven Jon — Chief Medical Officer
Shares
1,026
Price
$12.36
Total Value
$12.68K
Shares Held After
179,096
% of Holdings
0.6%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
100
Price
$5.08
Total Value
$508.30
Shares Held After
31,750
% of Holdings
0.3%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
377
Price
$5.08
Total Value
$1.92K
Shares Held After
31,850
% of Holdings
1.2%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
1,603
Price
$5.08
Total Value
$8.14K
Shares Held After
32,227
% of Holdings
4.7%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
24
Price
$5.08
Total Value
$121.85
Shares Held After
33,830
% of Holdings
0.1%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
2,986
Price
$66.41
Total Value
$198.30K
Shares Held After
85,211
% of Holdings
3.4%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
4,392
Price
$65.52
Total Value
$287.77K
Shares Held After
88,197
% of Holdings
4.7%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
58,368
Price
$1.43
Total Value
$83.47K
Shares Held After
1,409,511
% of Holdings
4.0%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
6,737
Price
$1.43
Total Value
$9.63K
Shares Held After
1,467,879
% of Holdings
0.5%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
2,708
Price
$1.43
Total Value
$3.87K
Shares Held After
1,474,616
% of Holdings
0.2%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
34,437
Price
$9.95
Total Value
$342.65K
Shares Held After
604,639
% of Holdings
5.4%
Oscar Health, Inc. (OSCR)
Baltrus Victoria — Chief Accounting Officer
Shares
4,638
Price
$13.39
Total Value
$62.10K
Shares Held After
216,112
% of Holdings
2.1%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
250
Price
$50.69
Total Value
$12.67K
Shares Held After
25,801
% of Holdings
1.0%
Oscar Health, Inc. (OSCR)
Liang Janet — President, Oscar Insurance
Shares
7,453
Price
$13.39
Total Value
$99.80K
Shares Held After
271,532
% of Holdings
2.7%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
5,466
Price
$17.92
Total Value
$97.97K
Shares Held After
613,471
% of Holdings
0.9%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
1,000
Price
$22.53
Total Value
$22.53K
Shares Held After
7,397
% of Holdings
13.5%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
100
Price
$7.06
Total Value
$706.00
Shares Held After
1,226,507
% of Holdings
0.0%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%
Oscar Health, Inc. (OSCR)
Blackley Richard Scott — Chief Financial Officer
Shares
19,221
Price
$13.39
Total Value
$257.37K
Shares Held After
1,466,660
% of Holdings
1.3%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
7
Price
$7.00
Total Value
$49.00
Shares Held After
44,918
% of Holdings
0.0%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
1,860
Price
$23.18
Total Value
$43.11K
Shares Held After
1,203,667
% of Holdings
0.2%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
14,292
Price
$22.67
Total Value
$323.99K
Shares Held After
1,205,527
% of Holdings
1.2%
Stoke Therapeutics, Inc. (STOK)
Krainer Adrian R. — Director
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
24,335
Price
$13.39
Total Value
$325.85K
Shares Held After
514,986
% of Holdings
4.5%
Showing 1551–1600 of 2026 transactions (page 32 of 41)